American Healthcare REIT, Inc. (AHR)
NYSE: AHR · Real-Time Price · USD
47.95
-0.45 (-0.93%)
Dec 26, 2025, 4:00 PM EST - Market closed
American Healthcare REIT Stock Forecast
Stock Price Forecast
The 10 analysts that cover American Healthcare REIT stock have a consensus rating of "Strong Buy" and an average price target of $51.8, which forecasts a 8.03% increase in the stock price over the next year. The lowest target is $37 and the highest is $60.
Price Target: $51.8 (+8.03%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 26, 2025.
Analyst Ratings
The average analyst rating for American Healthcare REIT stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 3 | 3 | 3 |
| Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 10 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $46 → $53 | Strong Buy | Maintains | $46 → $53 | +10.53% | Nov 26, 2025 |
| Citigroup | Citigroup | Hold Maintains $45 → $52 | Hold | Maintains | $45 → $52 | +8.45% | Nov 21, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $52 → $55 | Buy | Maintains | $52 → $55 | +14.70% | Nov 20, 2025 |
| UBS | UBS | Strong Buy Maintains $51 → $56 | Strong Buy | Maintains | $51 → $56 | +16.79% | Nov 17, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $47 → $55 | Buy | Maintains | $47 → $55 | +14.70% | Nov 13, 2025 |
Financial Forecast
Revenue This Year
2.26B
from 2.06B
Increased by 9.41%
Revenue Next Year
2.47B
from 2.26B
Increased by 9.26%
EPS This Year
0.42
from -0.29
EPS Next Year
0.73
from 0.42
Increased by 73.89%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 2.4B | 2.8B | ||
| Avg | 2.3B | 2.5B | ||
| Low | 2.1B | 2.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 17.8% | 26.0% | ||
| Avg | 9.4% | 9.3% | ||
| Low | 3.7% | 0.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.56 | 0.84 | |
| Avg | 0.42 | 0.73 | |
| Low | 0.30 | 0.57 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 99.2% | |
| Avg | - | 73.9% | |
| Low | - | 34.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.